Lv11
70 积分 2025-10-03 加入
Targeted therapeutic options based on the pathogenesis of IgA nephropathy
53分钟前
待确认
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
1小时前
已完结
Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
1小时前
已完结
What do clinical trials teach us about the pathophysiology of human IgA nephropathy?
1个月前
已关闭
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
2个月前
已完结
IgA Nephropathy: Core Curriculum 2021
2个月前
已完结
皖公网安备34019202002308
